- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01857375
A Study of Improved Efficacy, Safety and Compliance to Administer Insulin in Pen vs. Vial and Syringe
May 20, 2013 updated by: Jeffrey Rothman, Northwell Health
This research is to determine the use of insulin pens compared to syringe and vial therapy in adults newly begun on insulin therapy during their hospital stay.
Study Overview
Detailed Description
This research is to determine the use of insulin pens compared to syringe and vial therapy in adults newly begun on insulin therapy during their hospital stay.
Patients will have no prior experience using insulin or other self-administered injectable medicine.
The study will examine which method of administering insulin reduces dosing errors, causes a lower incidence of low blood sugars, increases adherence to therapy and with which method patients are more satisfied.
Study Type
Observational
Enrollment (Actual)
35
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Adults newly begun on insulin therapy during their hospital stay.
Description
Inclusion Criteria:
- Adult in hospital and diagnosed with diabetes; must have no prior experience using insulin or other self-administered injectable medicine. they must be able to prepare an injection and to self administer the insulin using either a pen device or syringe and vial. They must be willing to monitor their blood sugar three times per day and keep a diary of their sugar measurements and insulin doses.
Exclusion Criteria:
- Previously treated with injectable medicine
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Group receiving insulin via vial/syringe
This group will receive their insulin via vial/syringe
|
|
|
Insulin Pen
Patients receiving insulin via insulin pen
|
Insulin pen was compared to administration of insulin using standard syringes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Insulin Dosing Accuracy (in units)
Time Frame: Approximately one year
|
Whether the method of administering insulin would: 1) reduce dosing errors as measured by direct observation of patient performance, 2) reduce the risk of hypoglycemia, 3) increase adherence to insulin, 4) improve patient satisfaction.Dosing accuracy was measured by direct observation of subject's performance at follow-up visits.
|
Approximately one year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Reduce the Risk of hypoglycemia (assessed by patient diary)
Time Frame: 3 months
|
3 months
|
|
Adherence to prescribed dose of insulin (assess patient diaries and observation of used pens/vials)
Time Frame: 3 months
|
3 months
|
|
Patient satisfaction with method of insulin administration measured by questionnaire.
Time Frame: 3 months
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Jeffrey Rothman, MD, SIUH
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2009
Primary Completion (ACTUAL)
April 1, 2010
Study Completion (ACTUAL)
April 1, 2010
Study Registration Dates
First Submitted
May 13, 2013
First Submitted That Met QC Criteria
May 15, 2013
First Posted (ESTIMATE)
May 20, 2013
Study Record Updates
Last Update Posted (ESTIMATE)
May 21, 2013
Last Update Submitted That Met QC Criteria
May 20, 2013
Last Verified
May 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 09-029
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
University of North Carolina, Chapel HillAmerican Diabetes AssociationNot yet recruitingType 2 Diabetes Mellitus (T2DM) | Diabetes (DM) | Insulin Dependent Diabetes | Type 1 Diabetes (T1D) | Diabetes Education | Diabetes Care | Diabetes (Insulin-requiring, Type 1 or Type 2)United States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
University of North Carolina, Chapel HillAmerican Heart AssociationRecruitingType 2 Diabetes | Nutrition | Diabetes Type 2 | T2DM (Type 2 Diabetes Mellitus) | Diabetes Mellitis | T2DM | Diabetes EducationUnited States
-
University of Trás-os-Montes and Alto DouroCompletedType 2 Diabetes Mellitus | Diabetes-Related ComplicationsPortugal
-
Northern Care Alliance NHS Foundation TrustBrighter ABCompletedDiabetes type1 | Diabetes type2United Kingdom
-
VeraLight, Inc.InLight SolutionsUnknownGestational Diabetes | Insulin Dependent Diabetes | Non Insulin Dependent DiabetesUnited States
-
COUR Pharmaceutical Development Company, Inc.RecruitingType 1 Diabetes | Type 1 Diabetes Mellitus | T1DM | T1D | Type 1 Diabetes in Adolescence | Type 1 Diabetes in Children | Type 1 Diabetes Patients | Type 1 Diabetes Mellitis | T1DM - Type 1 Diabetes Mellitus | Type 1 Diabetes (Juvenile Onset)United States
-
Steno Diabetes Center CopenhagenNot yet recruitingDiabetes | Diabetes Type 1 | Diabetes Type 2 | Digital Health | Diabetes Care | Remote Patient MonitoringDenmark
Clinical Trials on Insulin Pen Device
-
Calibra Medical, Inc.Northwestern University; University of Texas Southwestern Medical Center; Henry... and other collaboratorsCompletedFeasibility Study of Finesse for Bolus Prandial Insulin Dosing Compared to Multiple Daily InjectionsDiabetes MellitusUnited States
-
Nanfang Hospital of Southern Medical UniversityRecruitingInjection | Gestational Diabetes | Blood Glucose, High | Glycemic ControlChina
-
SanofiCompletedType 2 DiabetesUnited States, Canada, Chile, Czech Republic, Estonia, France, Germany, Hungary, Italy, Latvia, Lithuania, Mexico, Poland, Romania, Russian Federation, Spain, Ukraine, United Kingdom
-
University of Maryland, BaltimoreMedtronicRecruiting
-
G2e Co., LtdCompletedPancreatogenic Diabetes Mellitus | Diabetes (Insulin-requiring, Type 1 or Type 2)Korea, Republic of
-
Companion Medical, Inc.Terminated
-
G2e Co., LtdNot yet recruitingDiabetes MellitusKorea, Republic of
-
Becton, Dickinson and CompanyTerminatedDiabetes Mellitus, Type 2United States, Canada
-
Second Affiliated Hospital, School of Medicine,...UnknownTime in Range | T2DM (Type 2 Diabetes Mellitus) | Needle-free InjectorChina
-
Fundación para la Investigación del Hospital Clínico...Not yet recruiting